HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Charles J Schneider Selected Research
Charles J Schneider Research Topics
Disease
8
Neoplasms (Cancer)
01/2022 - 06/2007
3
Breast Neoplasms (Breast Cancer)
08/2014 - 12/2009
2
Head and Neck Neoplasms (Head and Neck Cancer)
12/2019 - 07/2011
2
Disease Progression
12/2019 - 02/2009
2
Squamous Cell Carcinoma of Head and Neck
12/2019 - 11/2018
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2018 - 01/2002
2
Neoplasm Metastasis (Metastasis)
01/2018 - 06/2007
1
Adenocarcinoma
01/2022
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1
Margins of Excision
01/2022
1
Circulating Neoplastic Cells
01/2022
1
Colonic Neoplasms (Colon Cancer)
01/2022
1
Colorectal Neoplasms (Colorectal Cancer)
05/2021
1
Hemorrhage
12/2019
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2019
1
Hyperalgesia
01/2019
1
Anemia
11/2018
1
Injection Site Reaction
11/2018
1
Exanthema (Rash)
11/2018
1
Fever (Fevers)
11/2018
1
Chills
11/2018
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2017
1
Tonsillar Neoplasms
06/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2015
1
Leukemia
11/2012
1
Mucositis
07/2011
1
Stomatitis
07/2011
1
Xerostomia
07/2011
1
Prostatic Neoplasms (Prostate Cancer)
06/2007
1
Thrombocytopenia (Thrombopenia)
01/2002
Drug/Important Bio-Agent (IBA)
3
Platinum
IBA
10/2020 - 01/2019
3
Cetuximab (Erbitux)
FDA Link
11/2018 - 02/2009
2
Bevacizumab (Avastin)
FDA Link
12/2019 - 07/2018
2
Monoclonal Antibodies
IBA
12/2019 - 02/2009
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
08/2014 - 11/2012
2
Paclitaxel (Taxol)
FDA Link
Generic
08/2014 - 11/2012
2
Doxorubicin (Adriamycin)
FDA Link
Generic
08/2014 - 11/2012
1
Circulating Tumor DNA
IBA
01/2022
1
Carcinoembryonic Antigen
IBA
01/2022
1
Cell-Free Nucleic Acids
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
10/2020
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2019
1
Ice
IBA
01/2019
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2019
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2019
1
VTX-2337
IBA
11/2018
1
Biomarkers (Surrogate Marker)
IBA
11/2018
1
Pemetrexed (MTA)
FDA Link
07/2018
1
Carboplatin (JM8)
FDA Link
Generic
07/2018
1
Irinotecan (Camptosar)
FDA Link
Generic
10/2017
1
sacituzumab govitecan
IBA
10/2017
1
Type I DNA Topoisomerases (Topoisomerase I)
IBA
10/2017
1
Immunoconjugates (Immunoconjugate)
IBA
10/2017
1
Fibroblast Growth Factor 7
FDA Link
07/2011
1
Anthracyclines
IBA
12/2009
1
taxane
IBA
12/2009
1
enzastaurin
IBA
12/2009
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
02/2009
1
Growth Factor Receptors
IBA
02/2009
1
ErbB Receptors (EGF Receptor)
IBA
02/2009
1
Glycoproteins (Glycoprotein)
IBA
06/2007
1
Cytokines
IBA
06/2007
1
Transforming Growth Factor beta (TGF-beta)
IBA
06/2007
1
Endoglin
IBA
06/2007
1
Topotecan (Hycamtin)
FDA Link
Generic
01/2002
1
Gemcitabine
FDA Link
01/2002
1
Cisplatin (Platino)
FDA Link
Generic
01/2002
Therapy/Procedure
8
Therapeutics
01/2022 - 01/2002
5
Drug Therapy (Chemotherapy)
12/2019 - 02/2009
2
Immunotherapy
05/2021 - 11/2018
2
Radiotherapy
01/2018 - 06/2015
2
Adjuvant Chemotherapy
08/2014 - 11/2012
1
Cryotherapy (Therapy, Cold)
01/2019
1
Combination Drug Therapy (Combination Chemotherapy)
11/2018
1
Chemoradiotherapy
07/2011